(Q43997717)

28 November 2017

title

Electrocardiographic effects of rivastigmine (English)

1 reference

28 November 2017

1 reference

Joel Morganroth

1

1 reference

28 November 2017

Stephen Graham

series ordinal

2

1 reference

28 November 2017

Richard Hartman

series ordinal

3

1 reference

28 November 2017

Ravi Anand

series ordinal

4

1 reference

28 November 2017

publication date

1 May 2002

1 reference

The Journal of Clinical Pharmacology

28 November 2017

published in

1 reference

28 November 2017

volume

42

1 reference

28 November 2017

issue

5

1 reference

28 November 2017

page(s)

558-568

1 reference

Neurotransmitter-related enzymes and indices of hypoxia in senile dementia and other abiotrophies

28 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F00912700222011490

Alzheimer's disease and senile dementia: loss of neurons in the basal forebrain

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700222011490

Pharmacologic and Clinicopharmacologic Properties of SDZ ENA 713, a Centrally Selective Acetylcholinesterase Inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700222011490

Efficacy and safety of rivastigmine in patients with Alzheimer's disease: international randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700222011490

Prescribing patterns for nursing home residents in the US. The reality and the vision

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700222011490

Self-reported adverse drug reactions and related resource use. A study of community-dwelling persons 65 years of age and older.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700222011490

Adverse drug reactions. An overview of special considerations in the management of the elderly patient

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700222011490

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700222011490

Safety/tolerability trial of SDZ ENA 713 in patients with probable Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700222011490

10.1177/00912700222011490

21 January 2018

Identifiers

DOI

1 reference

28 November 2017

1 reference